Bintan, 7 February 2026 — idsMED Aesthetics officially introduced Obagi Medical as its newest portfolio in Indonesia during the idsMED Aesthetics Excellence Appreciation Award 2025 themed “Bloom Beyond Time,” held at Hotel Indigo Bintan Lagoi Beach.
The launch marks a strategic step by idsMED Aesthetics in strengthening Indonesia’s medical aesthetics ecosystem, particularly in science-based skincare and professional dermatology. Starting in 2026, Obagi Medical has officially appointed idsMED as its exclusive distributor in Indonesia, replacing the previous distributor.
The launch also signifies the start of the #ALegacyReintroduced campaign, an initiative to reintroduce Obagi Medical to the Indonesian market in a way that is more relevant to current industry developments. As a globally recognized dermatological brand, Obagi Medical is entering a new era in Indonesia through a more structured approach that prioritizes medical education, clear dermatology protocols, and long term collaboration with doctors and clinics.
Obagi Medical is a dermatological brand from the United States with more than 35 years of experience. Globally known for its science based skincare approach, Obagi offers professional skincare systems such as Nu Derm System, CLENZIderm M.D., ELASTIderm, Retinol, and Professional C Serum, formulated to address various skin concerns including acne, early aging, hyperpigmentation, and long term skin health maintenance. Under idsMED, Obagi Medical is expected to further elevate the standard of professional skincare in Indonesia.
Obagi Medical products are used based on medical prescription and dermatology protocols, where each treatment is customized through professional evaluation by a doctor, including the appropriate product regimen, active ingredient concentration, and safe and effective duration of use. This approach ensures that treatments are not generic, but measurable, controlled, and oriented toward long term skin health, positioning Obagi Medical as a professional skincare standard in modern aesthetic clinics.
On this occasion, Andy Rahardja, Vice President of idsMED Aesthetics, stated:
“To date, idsMED Aesthetics has reached more than 3,000 clinics across Indonesia, building a strong and sustainable medical network. The addition of Obagi Medical to our portfolio is part of idsMED’s broader vision to develop a comprehensive medical aesthetics ecosystem, from continuous education and medical technology to science based products. Through the #ALegacyReintroduced campaign, we are confident that Obagi’s presence will bring significant added value to our clinic partners and patients in Indonesia.”
Meanwhile, Marisa Theresia, Head of Aesthetics at idsMED, added:
“The idsMED Aesthetics Excellence Appreciation Award Gala 2025 is our annual agenda to appreciate all clinic partners who have grown and progressed with idsMED. This momentum becomes even more meaningful with the introduction of Obagi Medical, in line with our commitment to continuously deliver science based medical aesthetic solutions focused on long term skin health.”
This strategic collaboration is also strongly supported by Obagi Medical. Chris Driver, President of Asia Pacific Region at Obagi Medical, stated:
“We are proud to partner with idsMED Aesthetics as our new distributor in Indonesia. idsMED’s strong medical network, commitment to education, and long term vision align perfectly with Obagi’s mission to transform skin health globally. We are confident that together we can elevate the standard of professional skincare and deliver meaningful impact for patients and practitioners across Indonesia.”
Through the launch of Obagi Medical, idsMED Aesthetics further reinforces its position as a long term strategic partner for aesthetic clinics in Indonesia, while continuing to drive innovation, education, and sustainable growth in the medical aesthetics industry.
